Norway vs Solomon Islands: The number of people with susceptibility test result for rifampicin
Norway
69
in 2021
Solomon Islands
66
in 2021
Norway rank
114th
Solomon Islands rank
115th
The number of people with susceptibility test result for rifampicin over time
- Norway
- Solomon Islands
How they compare
Norway currently reports 69 against 66 in Solomon Islands, a difference of 3.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Norway ahead.
Norway ranks 114th and Solomon Islands ranks 115th of 155 countries.
Across the 2 decades both report, Norway averaged higher in 1 and Solomon Islands in 1.
Head to head by decade
| Decade | Norway | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 105.33 | 0 | 105.33 | Norway |
| 2020s | 75 | 86 | 11 | Solomon Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Norway or Solomon Islands?
- Norway, at 69 against 66 in Solomon Islands as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Norway and Solomon Islands?
- 3, with Norway ahead.
- How many years of comparable data are there for Norway and Solomon Islands?
- 5 years are reported by both, from 2017 to 2021.
- How do Norway and Solomon Islands rank globally for the number of people with susceptibility test result for rifampicin?
- Norway ranks 114th and Solomon Islands ranks 115th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.